Saturday, July 22, 2017 2:41:09 PM
United States, Florida
Study Site Recruiting
Port Orange, Florida, United States, 32127
Clinical Study Site Recruiting
Tampa, Florida, United States, 33609
http://www.wtsp.com/news/local/local-clinical-research-could-give-more-options-for-patients-suffering-from-psoriasis/452052810
Imagine living with a skin condition that leaves severe rashes all over your body.
We're talking about Psoriasis.
For years, people suffering from the condition had only one option to get rid of it, painful weekly injections.
For the past 8 years, Olga Clark has given herself two injections every week to treat her Psoriasis.
“I couldn't take a bath because the water burned my skin. My scalp was really severe to where I would scratch and I felt like I was bleeding,” says Clark.
She no longer has rashes on her skin, now but Olgas says at its peak, psoriasis took over her body.
“There was not a spot on me that was clear. my legs were covered, everything was covered,” says Clark.
In 2014, the first pill finally hit the market called Otezla.
In an effort to challenge the only that pill, Dr.Seth Forman, who is the Principal Investigator with Forward Clinical Trials, is conducting a local research study to put a new pill in the hands of patients like Olga.
“Olga is one of hundreds of patients that I have on these injectable medications. I can tell you most, if not all would rather take a pill like they do for their cholesterol or their blood pressure,” says Dr.Forman, MD.
Dr. Forman says the downside to only having one pill option is some patients could have an allergic reaction, then it's back to injections. That's why he says clinical research is so important.
“In order for us to get there for other skin conditions like Psoriasis, eczema. The only way we can do that is by having these what I call heroes participate in clinical research,” he says.
Giving people living with severe skin conditions, an option to possibly not feel the pain of a needle.
“If it didn't have to take a shot I would be happy. For them just to get on a pill, I think that's going to be great for them,” says Clark.
Otezla has mixed reviews. Some complain they have severe side effects. But others say it’s really helped them deal with their condition.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM